Physician profile
Michael Strother
NPI 1801960653
$442.60
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.84 · 2021: $81.45 · 2022: $57.28 · 2023: $174 · 2024: $72.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $241.32 | 2021-2024 | |
| Abbvie INC. | $70.61 | 2021-2024 | Skyrizi |
| Allergan, INC. | $29.49 | 2019 | |
| Dusa Pharmaceuticals, INC. | $27.35 | 2019 | |
| Ucb, INC. | $18.71 | 2021 | |
| Janssen Biotech, INC. | $14.54 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.07 | 2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $13.34 | 2023 | |
| Amgen INC. | $13.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Strother listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.